Defibrillators Market Trends

Growth Drivers

Growing Prevalence of Lifestyle Diseases Such as Hypertension and Diabetes - It was observed that, diabetes prevalence was estimated at 9.2% (460 million people) in 2019, and it is expected to increase to 10% (570 million) by 2030. Life style diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are leading causes for cardiovascular disease, are also on the rise in the population. Developing CVDs is strongly correlated with high blood pressure levels. Thus the rising cases of lifestyle diseases are expected to fuel global defibrillator market during the forecast period.
Increase in the Geriatric Population Around the Globe - A recent report from the World Bank states that there were be 747,238,580 people over 60 years of age living in the world at the end of 2021. The number is expected to increase in the future.
Rise in Medical Expenditures Worldwide - Healthcare expenditures in the United States increased by 9.7% to USD 4.1 trillion in 2020, representing 19.7% of GDP, according to the Centers for Medicare & Medicaid Services. Moreover, U.S. healthcare spending is expected to rise to USD 6.2 trillion by 2028, an increase of 5.4% annually.
Affective Training Programs and Awareness Campaigns About Defibrillators - For instance, an automated external defibrillator (AED) training program offered by the American Red Cross allows professionals to learn how and when to use AEDs.
Incidence of Spinocerebellar Ataxia (SCA) Around the Globe - It was observed that approximately 3 cases of SCA are reported to occur for every 10 thousand people throughout the world.

Challenges

Unawareness of Sudden Cardiac Arrest Among People – The unhealthy lifestyle has prompted the increase of cases of sudden cardiac arrest and heart attacks. However, people are not aware of the sudden cases and tend to avoid the signals. This trend is expected to slow down the utilization of defibrillators in the upcoming years.
Issues Associated with the Use of an Automated External Defibrillator
Availability of Non-Branded Local Defibrillators

Defibrillators Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	7.3%
Base Year Market Size (2024)	USD 12.73 billion
Forecast Year Market Size (2037)	USD 32.06 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of defibrillators is assessed at USD 13.48 billion.

The defibrillators market size was over USD 12.73 billion in 2024 and is anticipated to reach USD 32.06 billion by the end of 2037, witnessing around 7.3% CAGR during the forecast period i.e., between 2025-2037. Rising incidence of cardiovascular disease worldwide along with rise in medical expenditures will boost the market growth.

North America is projected to account for largest industry share by 2037, driven by large patient populations along with higher incidence of cardiovascular diseases in United States.

The major players in the market include Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, ZOLL Medical Corporation, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, Abbott Laboratories.

Defibrillators Market Trends